Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 6, 2022
Patent Application Number
17470471
Date Filed
September 9, 2021
Patent Citations
Patent Citations Received
Patent Primary Examiner
This invention relates to methods comprising administering a FAK inhibitor (e.g., VS-6063) in combination with a dual RAF/MEK inhibitor (e.g., CHS 126766) that are useful in the treatment of abnormal cell growth, such as cancer, in a subject such as humans.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.